Harvard Medical School9d
Stem Cell Therapy Repairs Cornea Damage Thought Irreversible
The cornea is the clear, outermost layer of the eye. Its outer border, the limbus, contains a large volume of healthy stem ...
‘Irreversible’ eye damage fixed by stem cells in human trial
Researchers successfully pulled off the first eye stem cell transplants to help heal cornea damage, and the results speak for ...
Medical Dialogues13d
Autologous Corneal Stem Cell Transplant Shows High Success in Repairing Corneal Injuries, Finds Study
USA: A clinical study has demonstrated that transplanted autologous corneal stem cells effectively repaired irreversible ...
Daily Excelsior3d
Swami Vivekananda Hospital starts Corneal Transplant Surgery
Correspondent JAMMU, Mar 15 Swami Vivekananda Medical Mission Charitable Hospital (SVMMCH), Ambphalla here has started the ...
Business Insider9d
OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain
LONDON and NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic ...
Clinical Pain Advisor6d
OKYO Pharma Seeks Fast Track for Urcosimod in Neuropathic Corneal Pain
OKYO Pharma has filed a Fast Track designation application for urcosimod in the treatment of neuropathic corneal pain.
Ophthalmology Times9d
OKYO Pharma files application for Fast Track designation with the FDA for urcosimod for the treatment of neuropathic corneal pain
Urcosmid is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune ...
Nasdaq9d
OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain
Jacob, Ph.D., Chief Executive Officer of OKYO Pharma. “Notably, neuropathic corneal pain falls into this category, and our application for Fast Track designation marks a significant milestone ...